PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D. Lehmann(Vanderbilt University Medical Center), Jennifer A. Pietenpol(Vanderbilt University)
Cited by 331
Related Papers
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
|Cancer Informatics|2012|303
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
|Nature Communications|2021|255
Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest
|Journal of Biological Chemistry|1998|230